Citation: D. Kaur et al., EFFECT OF IL-1-ALPHA ON THE RELEASE OF NOREPINEPHRINE IN RAT HYPOTHALAMUS, Journal of neuroimmunology, 90(2), 1998, pp. 122-127
Citation: Wz. Potter, EARLY CLINICAL DEVELOPMENT OF PSYCHOACTIVE-DRUGS - PROS AND CONS OF ACADEMIC COLLABORATIONS, Biological psychiatry, 43, 1998, pp. 274-274
Authors:
SCHMIDT ME
MATOCHIK JA
GOLDSTEIN DS
SCHOUTEN JL
ZAMETKIN AJ
POTTER WZ
Citation: Me. Schmidt et al., GENDER DIFFERENCES IN BRAIN METABOLIC AND PLASMA-CATECHOLAMINE RESPONSES TO ALPHA(2)-ADRENOCEPTOR BLOCKADE, Neuropsychopharmacology, 16(4), 1997, pp. 298-310
Authors:
CHEN G
YAN PX
HAWVER DB
POTTER WZ
MANJI HK
Citation: G. Chen et al., INCREASE IN AP-1 TRANSCRIPTION FACTOR DNA-BINDING ACTIVITY BY VALPROIC ACID, Neuropsychopharmacology, 16(3), 1997, pp. 238-245
Authors:
SCHMIDT ME
RISINGER RC
HAUGER RL
SCHOUTEN JL
HENRY M
POTTER WZ
Citation: Me. Schmidt et al., RESPONSES TO ALPHA(2)-ADRENOCEPTOR BLOCKADE BY IDAZOXAN IN HEALTHY MALE AND FEMALE VOLUNTEERS, Psychoneuroendocrinology, 22(3), 1997, pp. 177-188
Authors:
SCHMIDT ME
GOLDSTEIN DS
SCHOUTEN JL
MATOCHIK JA
KIM HG
POTTER WZ
Citation: Me. Schmidt et al., ACUTE ALPHA(2) BLOCKADE BY IDAZOXAN INCREASES INSULIN AND LOWERS PLASMA-GLUCOSE DURING POSITRON EMISSION TOMOGRAPHY, Psychopharmacology bulletin, 33(2), 1997, pp. 253-259
Authors:
BODICK NC
OFFEN WW
LEVEY AI
CUTLER NR
GAUTHIER SG
SATLIN A
SHANNON HE
TOLLEFSON GD
RASMUSSEN K
BYMASTER FP
HURLEY DJ
POTTER WZ
PAUL SM
Citation: Nc. Bodick et al., EFFECTS OF XANOMELINE, A SELECTIVE MUSCARINIC RECEPTOR AGONIST, ON COGNITIVE FUNCTION AND BEHAVIORAL SYMPTOMS IN ALZHEIMER-DISEASE, Archives of neurology, 54(4), 1997, pp. 465-473
Authors:
MITCHELL PB
MANJI HK
CHEN G
JOLKOVSKY L
SMITHJACKSON E
DENICOFF K
SCHMIDT M
POTTER WZ
Citation: Pb. Mitchell et al., HIGH-LEVELS OF G(S)ALPHA IN PLATELETS OF EUTHYMIC PATIENTS WITH BIOPOLAR AFFECTIVE-DISORDER, The American journal of psychiatry, 154(2), 1997, pp. 218-223
Authors:
JACOBSEN LK
FRAZIER JA
MALHOTRA AK
KAROUM F
MCKENNA K
GORDON CT
HAMBURGER SD
LENANE MC
PICKAR D
POTTER WZ
RAPOPORT JL
Citation: Lk. Jacobsen et al., CEREBROSPINAL-FLUID MONOAMINE METABOLITES IN CHILDHOOD-ONSET SCHIZOPHRENIA, The American journal of psychiatry, 154(1), 1997, pp. 69-74
Authors:
MANJI HK
BERSUDSKY Y
CHEN G
BELMAKER RH
POTTER WZ
Citation: Hk. Manji et al., MODULATION OF PROTEIN-KINASE-C ISOZYMES AND SUBSTRATES BY LITHIUM - THE ROLE OF MYOINOSITOL, Neuropsychopharmacology, 15(4), 1996, pp. 370-381
Authors:
CHEN G
MANJI HK
WRIGHT CB
HAWVER DB
POTTER WZ
Citation: G. Chen et al., EFFECTS OF VALPROIC ACID ON BETA-ADRENERGIC RECEPTORS, G-PROTEINS, AND ADENYLYL-CYCLASE IN RAT C6 GLIOMA-CELLS, Neuropsychopharmacology, 15(3), 1996, pp. 271-280
Citation: Mb. Stein et al., G-PROTEIN LEVEL QUANTIFICATION IN PLATELETS AND LEUKOCYTES FROM PATIENTS WITH PANIC DISORDER, Neuropsychopharmacology, 15(2), 1996, pp. 180-186
Authors:
CASTELLANOS FX
ELIA J
KRUESI MJP
MARSH WL
GULOTTA CS
POTTER WZ
RITCHIE GF
HAMBURGER SD
RAPOPORT JL
Citation: Fx. Castellanos et al., CEREBROSPINAL-FLUID HOMOVANILLIC-ACID PREDICTS BEHAVIORAL-RESPONSE TOSTIMULANTS IN 45 BOYS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER, Neuropsychopharmacology, 14(2), 1996, pp. 125-137
Authors:
SCHMIDT ME
ERNST M
MATOCHIK JA
MAISOG JM
PAN BS
ZAMETKIN AJ
POTTER WZ
Citation: Me. Schmidt et al., CEREBRAL GLUCOSE-METABOLISM DURING PHARMACOLOGICAL STUDIES - TEST-RETEST UNDER PLACEBO CONDITIONS, The Journal of nuclear medicine, 37(7), 1996, pp. 1142-1149
Citation: Wz. Potter, ADRENOCEPTORS AND SEROTONIN RECEPTOR FUNCTION - RELEVANCE TO ANTIDEPRESSANT MECHANISMS OF ACTION, The Journal of clinical psychiatry, 57, 1996, pp. 4-8
Authors:
MANJI HK
CHEN G
HSIAO JK
RISBY ED
MASANA MI
POTTER WZ
Citation: Hk. Manji et al., REGULATION OF SIGNAL-TRANSDUCTION PATHWAYS BY MOOD-STABILIZING AGENTS- IMPLICATIONS FOR THE DELAYED-ONSET OF THERAPEUTIC EFFICACY, The Journal of clinical psychiatry, 57, 1996, pp. 34-48
Authors:
LITMAN RE
SU TP
POTTER WZ
HONG WW
PICKAR D
Citation: Re. Litman et al., IDAZOXAN AND RESPONSE TO TYPICAL NEUROLEPTICS IN TREATMENT-RESISTANT SCHIZOPHRENIA - COMPARISON WITH THE ATYPICAL NEUROLEPTIC, CLOZAPINE, British Journal of Psychiatry, 168(5), 1996, pp. 571-579